KRd
Showing 1 - 25 of 50
Multiple Myeloma Trial in Worldwide (Carfilzomib Lenalidomide Dexamethasone, Isatuximab Carfilzomib Lenalidomide Dexamethasone)
Active, not recruiting
- Multiple Myeloma
- Carfilzomib Lenalidomide Dexamethasone
- Isatuximab Carfilzomib Lenalidomide Dexamethasone
-
Ostrava, Czechia
- +6 more
Jul 26, 2022
Long-term KRd in Relapsed and/or Refractory Multiple Myeloma
Not yet recruiting
- Multiple Myeloma in Relapse
- Multiple Myeloma, Refractory
- Carfilzomib
- +2 more
- (no location specified)
Aug 8, 2022
Multiple Myeloma Trial in Chicago (Carfilzomib, Lenalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Carfilzomib
- +3 more
-
Chicago, IllinoisUniversity Of Chicago Medicine Comprehensive Cancer Center
Jun 7, 2021
Newly Diagnosed Multiple Myeloma Trial in Austria, Germany (Elotuzumab, Carfilzomib, Lenalidomide)
Active, not recruiting
- Newly Diagnosed Multiple Myeloma
- Elotuzumab
- +4 more
-
Krems, Lower Austria, Austria
- +55 more
Jan 4, 2022
Smoldering Multiple Myeloma Trial in Spain (carfilzomib, Lenalidomide, Dexamethasone)
Active, not recruiting
- Smoldering Multiple Myeloma
- carfilzomib
- +3 more
-
Barcelona, Spain
- +15 more
Feb 15, 2021
Multiple Myeloma, New Diagnosis Tumor Trial in Italy (Carfilzomib, Lenalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- New Diagnosis Tumor
- Carfilzomib
- +2 more
-
Alessandria, Italy
- +41 more
Mar 24, 2022
Multiple Myeloma Trial in Germany (Allogeneic Stem Cells, carfilzomib/lenalidomide/dexamethasone (KRD),
Not yet recruiting
- Multiple Myeloma
- Allogeneic Stem Cells
- +8 more
-
Freiburg, Baden-Württemberg, Germany
- +31 more
Jan 5, 2023
Multiple Myeloma Trial in Seoul (Lenalidomide maintenance)
Recruiting
- Multiple Myeloma
- Lenalidomide maintenance
-
Seoul, Korea, Republic ofSamsung Medical Center
Aug 10, 2022
Relapsed or Refractory Multiple Myeloma Trial in Worldwide (Carfilzomib, Lenalidomide, Dexamethasone)
Active, not recruiting
- Relapsed or Refractory Multiple Myeloma
- Carfilzomib
- +2 more
-
Fountain Valley, California
- +107 more
Dec 7, 2022
Myeloma, Multiple Myeloma Trial in Chicago (Daratumumab, Carfilzomib, Lenalidomide)
Recruiting
- Myeloma
- Multiple Myeloma
- Daratumumab
- +3 more
-
Chicago, IllinoisThe University of Chicago
Sep 15, 2021
Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +11 more
-
Duarte, California
- +21 more
Jan 17, 2023
Multiple Myeloma, Primary Plasma Cell Leukemia, Extramedullary Multiple Myeloma Trial in Wuhan (Daratumumab, Carfilzomib,
Recruiting
- Multiple Myeloma
- +2 more
- Daratumumab
- +10 more
-
Wuhan, Hubei, ChinaInstitute of Hematology, Union Hospital, Tongji Medical College,
Nov 18, 2023
Multiple Myeloma Trial in Seoul (Carfilzomib 56 MG [Kyprolis], Pomalidomide, Dexamethasone)
Recruiting
- Multiple Myeloma
- Carfilzomib 56 MG [Kyprolis]
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Aug 19, 2022
Multiple Myeloma Trial in Charlotte (Elotuzumab)
Active, not recruiting
- Multiple Myeloma
-
Charlotte, North CarolinaLevine Cancer Institute
Jan 24, 2023
Relapsed and/or Refractory Multiple Myeloma Trial in Japan (Ixazomib, Bortezomib, Carfilzomib)
Completed
- Relapsed and/or Refractory Multiple Myeloma
- Ixazomib
- +4 more
-
Kamogawa, Chiba, Japan
- +22 more
Jul 27, 2022
Kyprolis® in Combination With Revlimid® and Dexamethasone or
Recruiting
- Multiple Myeloma in Relapse
-
Frankfurt, GermanyCentrum für Hämatologie und Onkologie Bethanien
Jun 2, 2022
Newly Diagnosed Multiple Myeloma Trial in Spain (Lenalidomide., Carfilzomib, Bortezomib)
Recruiting
- Newly Diagnosed Multiple Myeloma
- Lenalidomide.
- +6 more
-
A Coruña, Spain
- +64 more
Mar 12, 2021
Multiple Myeloma Trial in United States (bb2121, Fludarabine, Cyclophosphamide)
Active, not recruiting
- Multiple Myeloma
- bb2121
- +3 more
-
Scottsdale, Arizona
- +19 more
Jul 7, 2022
Interventional Drug in Placenta Previa Trial in Erbil (Tranexamic acid injection, Glucose water 5%)
Recruiting
- Interventional Drug in Placenta Previa
- Tranexamic acid injection
- Glucose water 5%
-
Erbil, Kurdistan Region, Iraq
- +1 more
Jan 19, 2023